approved EB-1A RFE Issued

Principal Data Scientist

Artificial Intelligence · India · 2025-03-12

Processing Time
120 days
Decision Date
2025-03-12
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Judging the work of others (Met)

The petitioner completed more than 20 peer reviews for high-impact journals and conferences.

Original scientific or scholarly contributions (Met)

The petitioner developed clinical-grade AI for tumor detection and safety frameworks for generative AI adopted in over 30 countries.

Scholarly articles (Met)

The petitioner authored 5 peer-reviewed journal articles and several technical papers featured in venues like PLOS ONE.

Why This Petition Was Approved

The approval was based on meeting three EB-1A criteria: scholarly articles, judging the work of others, and original scientific contributions. The petitioner demonstrated significant influence through over 200 citations and the adoption of his work in over 30 countries.

Request for Evidence (RFE)

Successfully Addressed

The RFE required further evidence of the major significance of the petitioner's original contributions. The response included detailed documentation of the adoption of his AI frameworks across 30 countries and additional expert testimony.

RFE Targets
Original scientific or scholarly contributions

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Evidence Submitted
  • 5 peer-reviewed journal articles and several technical papers/abstracts
  • Over 200 citations in AI, medical imaging, and healthcare informatics
  • More than 20 peer reviews for high-impact journals and conferences
  • Co-developed a digital pathology system for osteosarcoma detection with clinical-grade accuracy
  • Proposed a framework for evaluating risks and vulnerabilities in generative AI systems
  • Developed a model for predicting recurrence in oral squamous cell carcinoma
  • Adoption of work by independent researchers in over 30 countries

Similar Cases

Scientist

Healthcare · India

WeGreened EB-1A approved
Georgia 6 days 2024-07-31
The petition was approved based on a staggering 9,366 citations and a robust publication record including 9 peer-reviewed journal articles and 4 technical reports. The petitioner also demonstrated significant professional standing through 18 peer reviews of her peers' work. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.

Physician

Healthcare · India

WeGreened EB-1A rfe approved
232 days 2025-11-04
The approval was based on the petitioner's 13 peer-reviewed journal articles and 113 citations from independent researchers. Additionally, the petitioner demonstrated authority in the field by completing at least 10 professional peer reviews for leading medical journals. The evidence satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.

Machine Learning Engineer

Artificial Intelligence · India

WeGreened EB-1A rfe approved
Massachusetts 111 days 2025-12-06
The petition was approved based on a body of peer-reviewed work including six journal articles and three conference papers with over 400 citations. The client also demonstrated expertise through more than 30 peer reviews for leading academic journals. Additionally, the work attracted competitive research funding from prominent public and governmental organizations.

Director

Biotechnology · India

WeGreened EB-1A approved
New Jersey 10 days 2023-03-03
The petition was approved based on 26 peer-reviewed scientific articles which garnered 493 citations from researchers in at least 43 countries. Additionally, the petitioner demonstrated his expertise by conducting 40 peer reviews for 10 different journals. His significant role in the field was further validated by his work on patient isolation protocols and early decision-making for cancer treatments.

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-12.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 120 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 5

EB-1A Case Data

Scraped Case Data

Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist